作为潜在的抗癌剂设计,合成和评估聚乙烯-英多尔混合物
Yingjie Xiao1, Jiawei Tang1, Shuoyu Zeng1
1State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China.
一种新型的丁-醇混合体,18q通过直接抑制Janus激酶/信号转换器和转录3 (JAK/STAT3) 途径的激活器,诱导亡并抑制瘤生长,显示出强大的抗癌作用.
科学领域:
- 药用化学 医学化学
- 分子药理学分子药理学
- 癌症生物学 癌症生物学
背景情况:
- 固醇是一种天然化合物,通过向JAK/STAT3通路,显示出抗癌性质.
- 提高固醇的疗效对于开发新型癌症疗法至关重要.
研究的目的:
- 设计和合成固-醇混合物作为新型STAT3抑制剂.
- 评估这些混合物的抗癌活性和作用机制.
主要方法:
- 聚乙烯的分子杂交与内基架的分子杂交.
- 在体外抗癌试验 (IC50测定,增殖,迁移试验).
- 亡分析 (流细胞测量),西式斑点和细胞热转移试验 (CETSA).
主要成果:
- 化合物18q对C6和A549细胞表现出显著的抗瘤活性 (IC50值分别为1.84 ± 0.41 μM和4.81 ± 1.12 μM).
- 18q诱导了晚期亡,抑制了增殖和迁移,并抑制了STAT3酸化.
- 通过稳定其热降解,CETSA证实18q是直接的STAT3抑制剂.
结论:
- 18q是一种强大的STAT3抑制剂,具有显著的抗瘤活性.
- 聚乙-醇混合基架代表了开发针对JAK/STAT3途径的新型癌症治疗药物的有前途战略.
更多相关视频
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
相关概念视频
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
